Open Access Open Access  Restricted Access Subscription or Fee Access

Patient preferences for the pharmacological treatment of osteoarthritis using adaptive choice-based conjoint (ACBC) analysis: A pilot study

Basem Al-Omari

Abstract


Background: Patient preferences for pharmaceutical treatment of osteoarthritis have been investigated using Conjoint Analysis. Studies have identified the importance of side effects in determining preferences, but noted that methodological limitations precluded further investigation of additional attributes such as hepatic and renal toxicity.

Objective: Following on from a feasibility study of adaptive choice-based conjoint (ACBC) analysis, the aim of this study was to evaluate 8 medication attributes for the pharmaceutical treatment of osteoarthritis (OA).

Setting and Participants: Eleven participants were recruited from members of a Research Users’ Group (RUG) who had been diagnosed with osteoarthritis. RUG members individually complete the ACBC task.

Main outcome measures: The relative importance of each attribute and the utilities (part-worth) of each level of each attribute were estimated using ACBC built-in Hierarchical Bayes (HB).

Results: The combined relative importance of the 4 risk side-effect attributes when selecting osteoarthritis medication (kidney and liver side effects, heart attack and stroke side effects, stomach side effects and addiction) was 66% while the effectiveness attribute accounted for 8% of the relative importance of the medication decision.

Conclusions: In this study, the gap between relative importance of 4 side-effect attributes and expected benefit was 66% vs 8%. These preliminary findings indicate that OA patients are most concerned with the avoidance of adverse events and that there is a threshold above which expected benefit has little impact on patients’ medication preferences. The study highlights methodological features of ACBC that may be useful more generally in health services research, but the results must be interpreted in conjunction with the study limitations.


Keywords


Adaptive choice-based conjoint analysis, osteoarthritis, patient preferences, person-centered healthcare, pharmaceutical treatment

Full Text:

PDF

References


Fraenkel, L., Bogardus, S.T., Concato, J. & Wittink, D.R. (2004). Treatment options in knee osteoarthritis: the patient's perspective. Archives of Internal Medicine 164 (12) 1299-1304.

Fraenkel, L., Wittink, D.R., Concato, J. & Fried, T. (2004). Are preferences for cyclooxygenase-2 inhibitors influenced by the certainty effect? Journal of Rheumatology 31 (3) 591-593.

Fraenkel, L., Wittink, D,R., Concato, J. & Fried, T. (2004). Informed choice and the widespread use of antiinflammatory drugs. Arthritis and Rheumatism 51 (2) 210-214.

Giercksky, K.E., Husby, G., Rugstad, H.E. & Revhaug, A. (1988). Epidemiology of NSAID-induced gastrointestinal problems and the role of cimetidine in their prevention. Alimentary Pharmacology & Therapeutics 2 (1) 33-41.

Bessone, F. (2010). Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? World Journal of Gastroenterology 16 (45) 5651-5661.

Laine, L. (2002). The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors. Seminars in Arthritis and Rheumatism 32 (3 Supplement 1) 25-32.

Ratcliffe, J., Buxton, M., McGarry, T., Sheldon, R. & Chancellor, J. (2004). Patients' preferences for characteristics associated with treatments for osteoarthritis. Rheumatology 43 (3) 337-345.

Cunningham, C., Deal, K. & Chen, Y. (2010). Adaptive Choice-Based Conjoint Analysis A New Patient-Centered Approach to the Assessment of Health Service Preferences. The Patient 3 (4) 257-273.

Fraenkel, L. & Fried, T. (2008). If you want patients with knee osteoarthritis (OA) to exercise: tell them about NSAIDS. The Patient 1 (1) 21-26.

Orme, B. (2009). Which Conjoint Method Should I Use? Available from: http://www.sawtoothsoftware.com/download/techpap/whichmth.pdf. [Accessed: 05/07/2017].

Fraenkel, L., Suter, L., Cunningham, C.E. & Hawker, G. (2014). Understanding preferences for disease-modifying drugs in osteoarthritis. Arthritis Care & Research 66 (8) 1186-1192.

Al-Omari, B., Sim, J., Croft, P. & Frisher, M. (2015). Patient preferences for the pharmacological treatment of osteoarthritis: a feasibility study using adaptive choice-based conjoint analysis (ACBCA). European Journal for Person Centered Healthcare 3 (2) 253-260.

Al-Omari, B., Sim, J., Croft, P. & Frisher, M. (2017). Generating individual patient preferences for the treatment of osteoarthritis using adaptive choice-based conjoint analysis (ACBC). Rheumatology and Therapy 4 (1) 167-182.

Sawtooth (2013). SSI Web. Available from: http://www.sawtoothsoftware.com/products/ssiweb/howssiwebworks.shtml. [Accessed: 05/07/2017]

Hauber, A.B., Arden, N.K., Mohamed, A.F., Johnson, F.R., Peloso, P.M., Watson, D.J., Mavros, P., Gammaitoni, A., Sen, S.S. & Taylor, S.D. (2013). A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis. Osteoarthritis and Cartilage 21 (2) 289-297.




DOI: http://dx.doi.org/10.5750/ejpch.v5i2.1293

Refbacks

  • There are currently no refbacks.